欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称Nobilis Influenza H5N6
适用类别Veterinary
治疗领域
通用名/非专利名称adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5
活性成分inactivated whole avian influenza virus antigen of H5 subtype (strain H5N6, A/duck/Potsdam/2243/84)
产品号EMEA/V/C/000125
患者安全信息No
许可状态Withdrawn
ATC编码QI01AA23
是否额外监管No
是否仿制药或hybrid药物No
是否生物类似药No
是否附条件批准No
是否特殊情形Yes
是否加速审评Yes
是否罕用药No
上市许可日期2008/01/31
上市许可开发者/申请人/持有人Intervet International BV
人用药物治疗学分组
兽用药物治疗学分组Immunologicals for aves
欧盟委员会决定日期2010/07/05
修订号1
治疗适应症For active immunisation of chickens against avian influenza type A, subtype H5.Reduction of clinical signs, mortality and excretion of virus after challenge with a virulent H5N1 strain, were shown by two weeks after a single dose vaccination.Serum antibodies have been shown to persist in chickens for at least 7 months and studies performed with other vaccine strains show that serum antibodies would be expected to persist in chickens for at least 12 months after administration of two doses of vaccine.
适用物种Chicken
兽用药物ATC编码QI01AA23
首次发布日期2010/07/05
最后更新日期2010/07/26
产品说明书https://www.ema.europa.eu/en/documents/product-information/nobilis-influenza-h5n6-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/veterinary/EPAR/nobilis-influenza-h5n6
©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase